PDK1 and pancreatic neoplasm: We next determined the effect of the dual PDK1/Aurora Kinase A inhibitors on cell growth using a panel of five human pancreatic cancer cell lines displaying distinct genetic complexity, and on one non-malignant human pancreatic duct cell line (hTERT-HPNE).